Yu-Fang Huang
Papers
1
Total Citations
10
H-Index
1
About
Yu-Fang Huang is a clinical researcher specializing in gynecologic oncology, with a particular focus on optimizing treatment strategies for ovarian, tubal, and peritoneal cancers. Her major contributions center on real-world evidence, bridging the gap between clinical trial data and everyday patient care. Her landmark study, the ROBOT trial, is a comprehensive, eight-year retrospective analysis of adding bevacizumab to chemotherapy in Asian patients, providing crucial long-term data on prognostic impacts and adverse effects. This work, which has garnered 10 citations, is especially valuable for its focus on a population often underrepresented in pivotal trials, offering nuanced insights into the drug’s efficacy and safety in a real-world setting. Dr. Huang’s research is instrumental in refining treatment protocols, helping clinicians make more informed decisions about incorporating targeted therapies like bevacizumab into front-line and relapse therapy. Her dedication to evidence-based, patient-centered research continues to shape clinical practice and improve outcomes for women facing these challenging diagnoses.
Research Focus
Key Achievements
Top Papers
- 1